Cell Insight

Elsevier

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Cell Insight is an open-access journal published by Elsevier in Netherlands, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,150 USD. Declared review time at DOAJ: 13 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
2772-8927
Country
Netherlands
Languages
english
Access
Open access
Declared publication charge
2,150 USD
Articles in DOAJ
172
Declared review time
13 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2022-08-30
Indexing
DOAJ
APC
2,150 USD
Declared review time (DOAJ)
13 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

172

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

13weeks

Works in OpenAlex

189

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

23

i10-index

61

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2026-04-27
Added to DOAJ
2022-08-30
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
84%
ORCID iDs in current deposits
63%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9918557775706676
Classification4

Subjects (DOAJ)

Science: Biology (General)Medicine: Medicine (General)

LCC codes

QH301-705.5R5-920

Subject areas

  • interferon and immune responses
  • interferon and immune responses
  • RNA modifications and cancer
  • RNA modifications and cancer
  • Ubiquitin and proteasome pathways
  • Ubiquitin and proteasome pathways
  • RNA Research and Splicing
  • RNA Research and Splicing
Show all subjects (50)
  • Epigenetics and DNA Methylation
  • CRISPR and Genetic Engineering
  • CRISPR and Genetic Engineering
  • Epigenetics and DNA Methylation
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 and COVID-19 Research
  • Immune Cell Function and Interaction
  • RNA and protein synthesis mechanisms
  • Immune Cell Function and Interaction
  • Cancer-related gene regulation
  • Genomics and Chromatin Dynamics
  • Immunotherapy and Immune Responses
  • Viral Infections and Vectors
  • Viral Infections and Immunology Research
  • Cancer-related gene regulation
  • RNA and protein synthesis mechanisms
  • Viral Infections and Vectors
  • Genomics and Chromatin Dynamics
  • COVID-19 Clinical Research Studies
  • Immunotherapy and Immune Responses
  • Viral Infections and Immunology Research
  • COVID-19 Clinical Research Studies
  • Autophagy in Disease and Therapy
  • Inflammasome and immune disorders
  • Cancer, Hypoxia, and Metabolism
  • Virus-based gene therapy research
  • DNA Repair Mechanisms
  • Viral gastroenteritis research and epidemiology
  • Autophagy in Disease and Therapy
  • DNA Repair Mechanisms
  • Virus-based gene therapy research
  • Viral gastroenteritis research and epidemiology
  • Immune Response and Inflammation
  • Immune Response and Inflammation
  • T-cell and B-cell Immunology
  • Cancer, Hypoxia, and Metabolism
  • CAR-T cell therapy research
  • HIV Research and Treatment
  • Tuberculosis Research and Epidemiology
  • Cellular transport and secretion
  • T-cell and B-cell Immunology
  • Inflammasome and immune disorders

Keywords (DOAJ)

  • cell biology
  • immunology
  • microbiology
  • cancer biology
  • neuroscience

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: